Scholarlink

Objective <p>Traditional Chinese Medicine is a clinically recognized alternative approach for depression treatment in clinic. This study investigates the effects and mechanisms of tetramethylpyrazine (TMP), one of the most important active ingredients of <i>Ligusticum wallichii</i>, in the progression of depression.</p> Methods <p>The depression mouse model was established using the chronic unpredictable mild stress method. Mice with depression were treated with fluoxetine hydrochloride (FLX; 10&#xa0;mg/kg) and different concentrations of TMP (5, 10 and 20&#xa0;mg/kg, respectively). Open Field Test (OFT), Forced Swimming Test (FST) and Tail Suspension Test (TST) were used to evaluate depression behaviors in mice. The effects of TMP on hippocampal neurons were assessed through Nissl staining and measuring neurotransmitter levels. CREB/CRTC1 pathway-related gene expression and protein levels were ascertained via qRT-PCR and Western blotting.</p> Results <p>A higher concentration of TMP (20&#xa0;mg/kg) induced a pronounced reduction in the immobility time in FST (<i>P</i> &lt; 0.0001) and TST (<i>P</i> &lt; 0.01). However, TMP administration did not affect the path length in OFT. TMP treatment significantly increased the number of neurons (<i>P</i> &lt; 0.05) and the level of PSD95 (<i>P</i> &lt; 0.01), indicating that it improved the neuronal damage caused by depression. Meanwhile, 20&#xa0;mg/kg of TMP dramatically elevated neurotransmitter levels, including 5-hydroxytryptamine, dopamine and norepinephrine (<i>P</i> &lt; 0.001). TMP (5, 10 and 20&#xa0;mg/kg) significantly repressed SIK2 expression (<i>P</i> &lt; 0.001), and 20&#xa0;mg/kg of TMP distinctly induced the expression of CRTC1 (<i>P</i> &lt; 0.001), Calcineurin (<i>P</i> &lt; 0.001), CREB (<i>P</i> &lt; 0.001), and BDNF (<i>P</i> &lt; 0.001). Similar results were observed in the CREB/CRTC1 pathway-related protein levels (<i>P</i> &lt; 0.05).</p> Conclusions <p>These findings indicated that TMP can alleviate depression via the CREB/CRTC1 signaling pathway in a mouse model. This study provides a theoretical basis for the use of TMP as depression therapy in clinical practice.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Tetramethylpyrazine Protects Against Depression-Like Behaviors through CREB/CRTC1 Signaling Pathway in a Depression Mouse Model

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月15日

查看全文
  • Yulang Zhang,
  • Hongfei Liu,
  • Lujia Chen,
  • Jianyang Zhou,
  • Danni Xu,
  • Yanhua Deng

摘要

Objective

Traditional Chinese Medicine is a clinically recognized alternative approach for depression treatment in clinic. This study investigates the effects and mechanisms of tetramethylpyrazine (TMP), one of the most important active ingredients of Ligusticum wallichii, in the progression of depression.

Methods

The depression mouse model was established using the chronic unpredictable mild stress method. Mice with depression were treated with fluoxetine hydrochloride (FLX; 10 mg/kg) and different concentrations of TMP (5, 10 and 20 mg/kg, respectively). Open Field Test (OFT), Forced Swimming Test (FST) and Tail Suspension Test (TST) were used to evaluate depression behaviors in mice. The effects of TMP on hippocampal neurons were assessed through Nissl staining and measuring neurotransmitter levels. CREB/CRTC1 pathway-related gene expression and protein levels were ascertained via qRT-PCR and Western blotting.

Results

A higher concentration of TMP (20 mg/kg) induced a pronounced reduction in the immobility time in FST (P < 0.0001) and TST (P < 0.01). However, TMP administration did not affect the path length in OFT. TMP treatment significantly increased the number of neurons (P < 0.05) and the level of PSD95 (P < 0.01), indicating that it improved the neuronal damage caused by depression. Meanwhile, 20 mg/kg of TMP dramatically elevated neurotransmitter levels, including 5-hydroxytryptamine, dopamine and norepinephrine (P < 0.001). TMP (5, 10 and 20 mg/kg) significantly repressed SIK2 expression (P < 0.001), and 20 mg/kg of TMP distinctly induced the expression of CRTC1 (P < 0.001), Calcineurin (P < 0.001), CREB (P < 0.001), and BDNF (P < 0.001). Similar results were observed in the CREB/CRTC1 pathway-related protein levels (P < 0.05).

Conclusions

These findings indicated that TMP can alleviate depression via the CREB/CRTC1 signaling pathway in a mouse model. This study provides a theoretical basis for the use of TMP as depression therapy in clinical practice.